Eli Lilly and Company has announced changes to the labeling of Zyprexa and Symbyax, two brand-name atypical antipsychotics produced and sold by the company. Eli Lilly has updated the labeling to include more warning information on potentially harmful weight gain and blood sugar elevation that may result from taking the medications.
According to Eli Lilly, the label changes came about because of conversations with the FDA, as well as new analyses of the data from large clinical trials conducted by the company and others. The company will be sending a "Dear Healthcare Practitioner" letter to doctors about the new labeling, as well as informing consumer advocacy and professional associations.
The conclusion of this article appears on NaturalNews.com, the independent natural health news source for consumers. This article, along with other related articles and uncensored news on important consumer health topics, can be found at:
Zyprexa Warnings over Weight Gain, Blood Sugar Elevation : http://www.naturalnews.com/022887.html
NaturalNews is an independent natural health news resource that covers consumer news and how to improve health through foods, herbs, exercise and natural therapies. The site also warns consumers about the dangers of processed foods, pharmaceuticals, chemotherapy, environmental toxins and the failure of government regulators like the FDA.